Catalyst Wire Dossier Catalyst Wire Dossier

rhEndostatin

recombinant human endostatin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rhEndostatin, covering 2007-12-28 to 2007-12-28. Get the full timeline:

Most recent: Clinical Trial Update: rhEndostatin Protein Involving Pediatric Patients With Cancer [Phase 1]

See pricing